SINGAPORE: The Health Sciences Authority (HSA) is investigating whether there are problems with a batch of dermal fillers after a woman who was administered with it became blind.

The incident, which occurred in July, is the first local adverse event report for blindness resulting from dermal fillers, HSA said in response to queries from CNA on Tuesday (Sep 12).

Dermal fillers are classified by the HSA as Class D medical devices - the highest risk class.

Read more at Channel News Asia >>